docetaxel anhydrous has been researched along with fusaric acid in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (fusaric acid) | Trials (fusaric acid) | Recent Studies (post-2010) (fusaric acid) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 324 | 11 | 109 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | fusaric acid (IC50) |
|---|---|---|---|
| Dopamine beta-hydroxylase | Bos taurus (cattle) | 0.05 | |
| Dopamine beta-hydroxylase | Rattus norvegicus (Norway rat) | 0.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montero, M; Stack, BC; Ye, J | 1 |
1 other study(ies) available for docetaxel anhydrous and fusaric acid
| Article | Year |
|---|---|
Effects of fusaric acid treatment on HEp2 and docetaxel-resistant HEp2 laryngeal squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 7; Caspase 9; Cell Line, Tumor; Cell Survival; Cytokines; Docetaxel; Drug Resistance, Neoplasm; Fusaric Acid; Humans; Laryngeal Neoplasms; Poly(ADP-ribose) Polymerases; Taxoids; Time Factors | 2013 |